0001209191-16-122625.txt : 20160523
0001209191-16-122625.hdr.sgml : 20160523
20160523163458
ACCESSION NUMBER: 0001209191-16-122625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160519
FILED AS OF DATE: 20160523
DATE AS OF CHANGE: 20160523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dimension Therapeutics, Inc.
CENTRAL INDEX KEY: 0001592288
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463942159
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-401-0011
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colowick Alan
CENTRAL INDEX KEY: 0001316163
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37601
FILM NUMBER: 161669474
MAIL ADDRESS:
STREET 1: C/O THRESHOLD PHARMACEUTICALS, INC.
STREET 2: 1300 SEAPORT BOULEVARD, 5TH FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-19
0
0001592288
Dimension Therapeutics, Inc.
DMTX
0001316163
Colowick Alan
C/O DIMENSION THERAPEUTICS, INC.
840 MEMORIAL DRIVE, 4TH FLOOR
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
7.08
2016-05-19
4
A
0
32069
0.00
A
2026-05-18
Common Stock
32069
32069
D
The options shall vest in full on the earlier of May 19, 2017 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board.
/s/ Jean Franchi, as Attorney-in-Fact for Alan Colowick
2016-05-23